Condition: Bone Marrow Transplant Complications · Graft-versus-Host Disease · Sponsor: Massachusetts General Hospital
The goal of this study is to demonstrate the efficacy of a multidisciplinary group-based telehealth intervention (HORIZONS) compared to minimally enhanced usual care for improving self-management and quality of life for hematopoietic stem cell transplant (HSCT) survivors living with chronic graft-versus host disease, and to identify critical facilitators and barriers for HORIZONS implementation and adoption.
This description comes directly from the study's public registry record.
Lara Traeger PhD · 304-284-3012 · ltraeger@miami.edu
Areej El-Jawahri MD · 617-721-4000 · ael-jawahri@mgb.org
Always discuss trial participation with your own doctor first.
| University of Miami Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06910969